Table 1. Demographic and clinical characteristics of enrolled TB cases initiating treatment from 2012–2015 in Tororo municipality and Osokuru parish, Uganda.
TB Cases (N = 131) | N | % |
---|---|---|
Demographic Characteristics | ||
Age, median (IQR) | 36 (29–44) | |
Female | 48 | 37 |
Hospitalized at enrollment | 21 | 16 |
Marital Status | ||
Single | 23 | 18 |
Married | 57 | 44 |
Widowed/Divorced/Separated | 51 | 39 |
Live alone | 29 | 22 |
Residence in Tororo Municipality (vs. Osukuru) | 95 | 73 |
Residence in study community ≥ 6 months prior to TB diagnosis | 121 | 92 |
Clinical Characteristics | ||
Sputum Microscopy* AFB positive |
95 |
73 |
AFB negative | 34 | 26 |
MTB culture positive (104/131 with sputum culture) | 84/104 | 81 |
New TB Diagnosis | 116 | 89 |
Prior TB Diagnosis | 15 | 11 |
Defaulted during past treatment | 8 | |
Completed prior treatment (recurrent TB) | 7 | |
Site of TB Involvement | ||
Pulmonary TB | 121 | 92 |
Pulmonary & Extrapulmonary TB | 7 | 5 |
Extrapulmonary TB | 3 | 2 |
Cough duration, median | 6 weeks | |
HIV-infected (N = 127 accepted HIV testing) | 66/127 | 52 |
In HIV care | 53/66 | 80 |
On antiretroviral therapy at enrollment | 21/66 | 32 |
Mean CD4+ cell count, cells/μL (range)** | 260 (5–701) | |
Smoke tobacco | 18 | 14 |
Any alcohol use | 76 | 58 |
Diabetes, self-reported | 4 | 3 |
*2 participants with missing microscopy results
** CD4+ count only available for 23/66 (35%) HIV-infected participants